Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    "Progressive non-fluent aphasia"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Conditions: Predicted Tauopathies, Including:;   Progressive Supranuclear Palsy;   Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17;   Corticobasal Degeneration Syndrome;   Progressive Nonfluent Aphasia
Interventions: Drug: davunetide (AL-108, NAP);   Drug: Placebo nasal spray
2 Recruiting PiB PET Scanning in Speech and Language Based Dementias
Conditions: PPA;   Primary Progressive Aphasia;   Aphasia;   Non-fluent Aphasia;   Semantic Dementia;   Apraxia of Speech;   Primary Progressive Nonfluent Aphasia;   Progressive Aphasia
Interventions: Drug: C-11 PiB;   Drug: F-18 FDG
3 Enrolling by invitation Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
Conditions: PPA;   Non-fluent Aphasia;   Apraxia of Speech;   Primary Progressive Non-fluent Aphasia;   Primary Progressive Aphasia
Intervention: Drug: FDG Fluorodeoxyglucose 18
4 Recruiting Language in Primary Progressive Aphasia
Condition: Primary Progressive Aphasia
Intervention:

Indicates status has not been verified in more than two years